title: Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.
authors.affiliation: Department of Pneumology-Allergy, Puerta del Mar University Hospital, Cádiz, Spain.
authors.forename: Diego
authors.initials: D
authors.lastname: Gutiérrez-Fernández
authors.affiliation: Department of Allergy, Hospital Nuestra Señora del Prado, Talavera de la Reina, Spain. Electronic address: a.morenoancillo@gmail.com.
authors.forename: Álvaro
authors.initials: Á
authors.lastname: Moreno-Ancillo
authors.affiliation: Joaquín Pece Primary Care Center, San Fernando, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Foncubierta-Fernández
authors.affiliation: Pediatric Department, Puerta del Mar University Hospital, Cádiz, Spain.
authors.forename: Isabel
authors.initials: I
authors.lastname: López-Martínez
authors.affiliation: Pediatric Department, Puerta del Mar University Hospital, Cádiz, Spain.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Lechuga-Sancho
authors.affiliation: Hospital Pharmacy, Puerta del Mar University Hospital, Cádiz, Spain.
authors.forename: María José
authors.initials: MJ
authors.lastname: Fernández-Anguita
mesh_terms: D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000628:therapy*; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000172:deficiency* / Q000235:genetics; D036341:Intercellular Signaling Peptides and Proteins / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; C065700:myotrophin; D007334:Insulin-Like Growth Factor I